EBOla Post-Exposure Prophylaxis

Clinical trial NCT06841614 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06841614
Sponsor: ANRS, Emerging Infectious Diseases
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ebola Virus Disease

Start date: 2026-09-01
Primary completion: 2027-08-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.